HERTRAZ 440 (trastuzumab) Intravenous Infusion

Description Trastuzumab, marketed under the brand name HERTRAZ 440, It is an prescription medication that has been approved in 1998 to treat HER2 metastatic breast cancer. In 2006, the FDA approved Herceptin to treat HER2 early breast cancer. What is HERTRAZ 440 (Trastuzumab) ? Hertraz is indicated for the treatment of metastatic breast cancer patients who have human epidermal growth factor receptor 2 (HER2)-overexpressing tumours. Early Breast Cancer (EBC) Hertraz is indicated for the treatment of adult patients with HER2-positive early breast cancer. How to order approved “HERTRAZ 440 (Trastuzumab) for Injection” Medicine? HERTRAZ 440 (Trastuzumab)  is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing HERTRAZ 440 and arranging delivery to your location, please get in touch with Mr. Rakesh at 91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.